COVID-19

COVID-19

#pubmed #!RESEARCH #Covid-19
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection-mass spectrometry was used for the discovery of botanical ligands to the …
·pubmed.ncbi.nlm.nih.gov·
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants